405 filings
Page 11 of 21
CT ORDER
3j5rsfqm
4 Apr 17
Confidential treatment order
12:00am
6-K
el7b0 ea4
21 Mar 17
Annual & Special Meeting of Shareholders
12:00am
6-K
az5655ss sgmri97z2x
16 Mar 17
Primary Document
12:00am
6-K
o5hl0sj84qg6xymim
28 Feb 17
Primary Document
12:00am
6-K
zv3dn0avp0v 7l39f
24 Feb 17
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR
12:00am
6-K
yvjbzxn6
10 Feb 17
Primary Document
12:00am
6-K
ddgz2x88fgeof
2 Feb 17
Primary Document
12:00am
6-K
cbb4aa1gr
6 Jan 17
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical
12:00am
6-K
d18p3
29 Dec 16
Primary Document
12:00am
6-K
xjdwpanzjvfbguauu
21 Dec 16
Intellipharmaceutics Announces Issuance of U.S. and Canadian Patents Covering Aspects of its PODRAS™ Overdose Technology
12:00am
6-K
efusm rbt
29 Nov 16
Intellipharmaceutics to Present at the LD Micro Main Event
12:00am
6-K
b2um3x
25 Nov 16
Primary Document
12:00am
6-K
el73qkf cbyztjg7hn6x
14 Oct 16
Intellipharmaceutics to Present at Dawson James Securities Growth Stock Conference
12:00am
6-K
s3qmd12a9dhwp5elwq1
14 Oct 16
Primary Document
12:00am
6-K
vr567f8t 4ec
11 Oct 16
Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Mallinckrodt
12:00am
6-K
zdylsjjd06 iil2
11 Oct 16
Primary Document
12:00am
6-K
0rf lrv714z0
6 Oct 16
Current report (foreign)
12:00am
6-K
i4kiee sg
22 Sep 16
Current report (foreign)
12:00am
6-K
3vm7s9yf
13 Sep 16
Current report (foreign)
12:00am